14-58646760-T-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4BP6_ModerateBS2_Supporting
The NM_001079520.2(DACT1):c.2026T>A(p.Tyr676Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001079520.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DACT1 | NM_001079520.2 | c.2026T>A | p.Tyr676Asn | missense_variant | 4/4 | ENST00000395153.8 | NP_001072988.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DACT1 | ENST00000395153.8 | c.2026T>A | p.Tyr676Asn | missense_variant | 4/4 | 5 | NM_001079520.2 | ENSP00000378582.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 30AN: 250236Hom.: 0 AF XY: 0.0000959 AC XY: 13AN XY: 135564
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461726Hom.: 0 Cov.: 34 AF XY: 0.0000193 AC XY: 14AN XY: 727170
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 04, 2024 | The c.2137T>A (p.Y713N) alteration is located in exon 4 (coding exon 4) of the DACT1 gene. This alteration results from a T to A substitution at nucleotide position 2137, causing the tyrosine (Y) at amino acid position 713 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 02, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at